1[1]Weintraub M, Rassin T, Eisenberg S, et al. Continuous intravenous heparin administration in humans causes a decrease in serum lipolytic activity and accumulation of chylomicrons in circulation. J Lipid Res, 1994, 35:229-238. 被引量：1
2[2]Psaty BM, Anderson M, Kronmal RA, et al. The association between lipid levels and the risks of incident myocardial infarction, stroke, and total mortality: The Cardiovascular Health Study. J Am Geriatr Soc, 2004, 52:1639-1647. 被引量：1
3[3]Weverling-Rijnsburger AW, Jonkers IJ, Van Exel E, et al.High-density vs low-density lipoprotein cholesterol as the risk factor for coronary artery disease and stroke in old age. Arch Intern Med, 2003, 163:1549-1554. 被引量：1
4[4]Lewis SJ. Statin therapy in the elderly: observational and randomized controlled trials support event reduction. Am J Geriatr Cardiol, 2004, 13(3 Suppl 1):10-16. 被引量：1
5[5]Mungall MM, Gaw A. Statin therapy in the elderly. Curr Opin Lipidol, 2004, 15:453-457. 被引量：1
6[6]Foody JM, Krumholz HM. Are statins indicated for the primary prevention of CAD in octogenarians? antagonist viewpoint. Am J Geriatr Cardiol, 2003, 12:357-360. 被引量：1
7[7]Bang LM, Goa KL. Pravastatin: a review of its use in elderly patients. Drugs Aging, 2003,20:1061-1082. 被引量：1
8[8]Wenger NK. Usefulness of lipid-lowering therapy in elderly patients. Am J Cardiol, 2002, 90:870-871. 被引量：1
9[9]Scranton R, Sesso HD, Stampfer MJ, et al. Predictors of 14-year changes in the total cholesterol to high-density lipoprotein cholesterol ratio in men. Am Heart J, 2004,147:1033-1038. 被引量：1
10[10]Lavie CJ. Treatment of hyperlipidemia in elderly persons with exercise training, nonpharmacologic therapy, and drug combinations. Am J Geriatr Cardiol, 2004,13(3 Suppl 1) :29-33. 被引量：1
2Ko DT, Alter DA, Newman AM, et al. Association between lipid testing and statin therapy in acute myocardial infarction patients. Am Heart J, 2005, 150(3): 419-425. 被引量：1
3Schatz I J, Masaki K, Yano K, et al. Cholesterol and all cause mortality in elderly people from the Honolulu Heart Program: a cohort study. Lancet,2001, 358(9279) : 351-355. 被引量：1
4Brown DF, Kinch SH, Doyle JT. Serum triglycerides in health and in isehemie heart disease. N Engl J Med, 1965, 273 (18) : 947-952. 被引量：1
5Shepherd J, Blauw GJ, Murphy MB, et al. Pravastatin in elder- ly individuals at risk of vascular disease(PROSPER): a ran domized controlled trial. Lancet,2002,360(9346) : 1623-1640. 被引量：1
6The Scandinavian Simvastatin Survival Study Group.Randomi-sed trial of cholesterol lowering in 4444 patients with coronary hert disease:the Scandinavian Simvastatin Survival Study(4S)[J].Lancet,1994,344(8934):1383. 被引量：1
9Baigent C,Keech A,Kearney PM. the Cholesterol Treatment Trialists'(CTT)Collaborators:Efficacy and safety of cholesterol-lowering treatment:prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins[J].{H}LANCET,2005.1267-1278. 被引量：1
10Wenger NK,Lewis SJ. Use of statin therapy to reduce cardiovascular risk in older patients[J].Curr Gerontol Geriatr Res,2010.915296. 被引量：1
